Research compound supplied in Australia by Pulse Biolabs for laboratory use. Available in 10mg.
Alpha-MSH darkens skin and also calms inflammatory signalling. KPV is the three-amino-acid end of it, studied to see whether the second job survives on its own.
KPV is a three-amino-acid fragment (lysine-proline-valine) from the end of alpha-melanocyte-stimulating hormone, a hormone involved in both pigmentation and inflammatory signalling. It is studied to test whether the hormone’s anti-inflammatory activity can be separated from its effect on skin colour. The evidence is preclinical: cultured intestinal cells and mouse models of colitis, mostly with oral delivery. No human trial of KPV was identified.
Read the full research note →| Presentation | Code | Status | Price |
|---|---|---|---|
| 10mg | KPV | In stock | $80 |
No batch-specific test report is currently published for this product. What a report does and does not show.
Supplied as lyophilised (freeze-dried) powder in a sealed vial. Store sealed and protected from light at the conditions stated on the product label or supplied specification. Solvent choice, concentration and handling after reconstitution depend on the compound and on the laboratory’s own procedures, and are not specified here.
KPV is not an approved medicine in Australia and is not listed in the Poisons Standard (June 2026). No overseas regulator has approved KPV as a medicine.
Status checked 2026-09-23. Details and sources in the research note.